Jean-Marc Herbert

Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric properties.

Jie Zhang, Harald Schwalbe, Francesco Luigi Gervasio, 2013, Cancer cell.

Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration

Till Acker, Can Ince, Lieve Moons, 2001, Nature Genetics.

Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions

Till Acker, Ulf Eriksson, Ingeborg Stalmans, 2001, Nature Medicine.

Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1

Christoph Dehio, Danica Stanimirovic, Lieve Moons, 2003, Nature Medicine.

5-Chlorothiophene-2-carboxylic acid [(S)-2-[2-methyl-3-(2-oxopyrrolidin-1-yl)benzenesulfonylamino]-3-(4-methylpiperazin-1-yl)-3-oxopropyl]amide (SAR107375), a selective and potent orally active dual thrombin and factor Xa inhibitor.

Peter Florian, Markus Follmann, Frederic Petit, 2013, Journal of medicinal chemistry.

Molecular Mechanism of SSR128129E, an Extracellularly Acting, Small-Molecule, Allosteric Inhibitor of FGF Receptor Signaling.

Harald Schwalbe, Francesco Luigi Gervasio, Frederic Rousseau, 2016, Cancer cell.

Effects of SanOrg123781A, a Synthetic Hexadecasaccharide, in a Mouse Model of Electrically Induced Carotid Artery Injury: Synergism with the Antiplatelet Agent Clopidogrel

N. Roome, J. Herbert, R. Masson, 2004, Journal of Pharmacology and Experimental Therapeutics.

In Vivo and In Vitro Characterization of the Novel Antiarrhythmic Agent SSR149744C: Electrophysiological, Anti-Adrenergic, and Anti-Angiotensin II Effects

Patrick Gautier, J. Herbert, D. Nisato, 2004, Journal of cardiovascular pharmacology.

Peroxisome Proliferator-activated Receptor α Activators Improve Insulin Sensitivity and Reduce Adiposity*

Bruno Derudas, Timothy M. Willson, L. Madsen, 2000, The Journal of Biological Chemistry.

The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts.

Pascual Ferrara, Françoise Bono, P. Ferrara, 2006, Proceedings of the National Academy of Sciences of the United States of America.